How to Help Your Patients Find Theo-24 XR in Stock: A Provider's Guide

The theophylline extended-release shortage has created a persistent access challenge for patients who depend on Theo-24 XR (and its generic equivalents) for chronic asthma and COPD management. As a prescriber, your guidance and proactive communication can make a significant difference in whether patients experience dangerous gaps in therapy.

This guide provides practical tools, clinical strategies, and patient communication resources to help your theophylline-dependent patients navigate the shortage.

Identify Which of Your Patients Are at Risk

The patients most at risk from supply disruptions are those who:

Are prescribed theophylline as their sole maintenance bronchodilator (no concurrent inhaled therapy).

Have moderate-to-severe COPD or persistent asthma where inadequate bronchodilation poses a serious health risk.

Are prescribed the 400 mg strength, which has the most significant supply disruption.

Have limited mobility, fixed income, or other barriers that make it harder to search multiple pharmacies.

Recommend medfinder to Patients Who Can't Find Their Medication

One of the most practical tools you can share is medfinder for Providers. medfinder calls pharmacies near the patient's location to check real-time availability, then texts the patient results. This saves patients — and your office staff — the burden of calling dozens of pharmacies.

You can include medfinder in your patient discharge instructions or post-visit summaries for theophylline patients: "If you have trouble finding your theophylline prescription, visit medfinder.com to locate pharmacies near you with it in stock."

Write Flexible Prescriptions

Help patients navigate availability by writing prescriptions that allow substitution within clinically safe parameters:

Allow equivalent splitting: Note in the prescription that "two 200 mg capsules may be substituted for one 400 mg capsule if unavailable" (with appropriate serum level monitoring).

Authorize manufacturer substitution: Do not mark prescriptions "brand name medically necessary" if a generic equivalent is acceptable. This gives pharmacists the flexibility to source from any available manufacturer.

Consider longer supply prescriptions: Where clinically appropriate and allowed by insurance, 90-day supply prescriptions reduce refill frequency and give patients more lead time to locate stock.

Provide a Clear Action Plan for Supply Gaps

At each visit for theophylline-dependent patients, briefly discuss what to do if they can't find their medication:

Start the refill search 7–10 days before running out.

Use medfinder to check availability at pharmacies nearby.

Call the office before running out — do not simply stop taking the medication.

Ask about independent pharmacies, compounding pharmacies, or mail-order options.

Monitor Serum Levels After Any Change

Serum theophylline monitoring is already a routine requirement, but supply disruptions create additional occasions for monitoring:

When a patient switches manufacturers (check within 3–5 days).

When dose or dosing interval is changed due to available strength differences.

When a patient resumes theophylline after a gap of 5 or more days.

Compounding as a Last Resort

For patients who cannot find theophylline through any standard channel, compounding pharmacy preparation is a viable option. Compounded theophylline capsules can be prepared in custom strengths. Note that compounded formulations are not subject to the same bioequivalence standards as FDA-approved generics, so serum level monitoring is especially important after initiating a compounded product.

When to Consider Transitioning Off Theophylline

If a patient has experienced multiple supply gaps, struggles with serum monitoring, or would benefit clinically from inhaled therapy, this is an appropriate time for a therapeutic transition. See our provider shortage briefing for a full summary of alternatives and transition guidance.